{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:05Z","timestamp":1790959145380,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2020M682684"],"award-info":[{"award-number":["2020M682684"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["20203010"],"award-info":[{"award-number":["20203010"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004924","name":"Guangxi Traditional Chinese Medical University","doi-asserted-by":"publisher","award":["2020KJCX-KTYJ-131"],"award-info":[{"award-number":["2020KJCX-KTYJ-131"]}],"id":[{"id":"10.13039\/501100004924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZZYSM202106009"],"award-info":[{"award-number":["SZZYSM202106009"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenerative disorder and seriously affects quality of life globally. Moxibustion is widely used to treat neurodegenerative diseases in the clinic and has achieved a beneficial clinical effect. However, strict control and high-quality randomized controlled trials are still lacking. Therefore, this trial aims to evaluate the clinical efficacy and safety of moxibustion in patients with PD and preliminarily explore the underlying mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a randomized, single-blind and placebo-controlled trial design in which 70 eligible participants will be randomly divided into a moxibustion group and a sham moxibustion group. Baihui (DU20) and Sishenchong (EX-HN1) are selected for both groups. The treatment will be performed for 30\u00a0min per session, two sessions a week for 8\u00a0weeks. The mean change in MDS-UPDRS scores (including MDS-UPDRS II, III subscale scores and total scores) from baseline to the observation points will be the primary outcome. The secondary outcomes will include scores on the Parkinson\u2019s Disease Questionnaire-39 (PDQ-39), Fatigue Severity Scale (FSS), Parkinson Disease Sleep Scale (PDSS), Montreal Cognitive Assessment (MoCA), and Self-Rating Depression Scale (SDS) as well as the Wexner constipation score. All the above outcomes will be assessed at 4 and 8\u00a0weeks. Laboratory blood biochemical analysis and functional magnetic resonance imaging (fMRI) will be conducted at baseline and at the end of treatment to explore the potential mechanisms of moxibustion in regulating PD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>In conclusion, the results of this trial will reveal whether moxibustion is effective for treating motor and nonmotor symptoms in PD. This trial will also preliminarily explore the underlying mechanism of the regulatory effect of moxibustion in PD, which will contribute to providing a theoretical basis for the treatment of PD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov ChiCTR2000029745. Registered on 9 August 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-023-03995-w","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T03:10:54Z","timestamp":1686539454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Moxibustion treatment for Parkinson\u2019s disease: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Chunxiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3798-5547","authenticated-orcid":false,"given":"Meiling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"3995_CR1","doi-asserted-by":"crossref","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","DOI":"10.1016\/S0140-6736(14)61393-3"},{"issue":"11","key":"3995_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"Collaborators GBDPsD","year":"2018","unstructured":"Collaborators GBDPsD. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol"},{"issue":"36","key":"3995_CR3","doi-asserted-by":"publisher","first-page":"E989","DOI":"10.1503\/cmaj.181504","volume":"191","author":"D Grimes","year":"2019","unstructured":"Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M, et al. Canadian guideline for Parkinson disease. CMAJ. 2019;191(36):E989\u20131004.","journal-title":"CMAJ"},{"key":"3995_CR4","doi-asserted-by":"publisher","first-page":"j1951","DOI":"10.1136\/bmj.j1951","volume":"358","author":"G Rogers","year":"2017","unstructured":"Rogers G, Davies D, Pink J, Cooper P. Parkinson\u2019s disease: summary of updated NICE guidance. BMJ. 2017;358:j1951.","journal-title":"BMJ"},{"issue":"6","key":"3995_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548\u201360.","journal-title":"JAMA"},{"key":"3995_CR6","doi-asserted-by":"crossref","unstructured":"Li BD, Bi ZY, Liu JF, Si WJ, Shi QQ, Xue LP, et al. Adverse effects produced by different drugs used in the treatment of Parkinson\u2019s disease: a mixed treatment comparison. CNS Neurosci Ther. 2017;23(10):827\u201342.","DOI":"10.1111\/cns.12727"},{"issue":"9","key":"3995_CR7","first-page":"610","volume":"25","author":"JF Zhang","year":"2005","unstructured":"Zhang JF, Sun GS, Zhao GH. Observation on therapeutic effect of herbs-partitioned moxibustion on Parkinson disease of 54 cases. Zhongguo Zhen Jiu. 2005;25(9):610\u20132.","journal-title":"Zhongguo Zhen Jiu"},{"key":"3995_CR8","doi-asserted-by":"publisher","first-page":"379291","DOI":"10.1155\/2013\/379291","volume":"2013","author":"H Deng","year":"2013","unstructured":"Deng H, Shen X. The mechanism of moxibustion: ancient theory and modern research. Evid Based Complement Alternat Med. 2013;2013:379291.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3995_CR9","first-page":"6668249","volume":"2021","author":"Z Huang","year":"2021","unstructured":"Huang Z, Si W, Li X, Ye S, Liu X, Ji Y, et al. Moxibustion protects dopaminergic neurons in Parkinson\u2019s disease through antiferroptosis. Evid Based Complement Alternat Med. 2021;2021:6668249.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3995_CR10","doi-asserted-by":"publisher","first-page":"2735492","DOI":"10.1155\/2019\/2735492","volume":"2019","author":"J Lu","year":"2019","unstructured":"Lu J, Liu X, Tian Y, Li H, Ren Z, Liang S, et al. Moxibustion exerts a neuroprotective effect through antiferroptosis in Parkinson\u2019s disease. Evid Based Complement Alternat Med. 2019;2019:2735492.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"04","key":"3995_CR11","first-page":"268","volume":"49","author":"J Liu","year":"2016","unstructured":"Liu J. Chinese diagnostic criteria for Parkinson\u2019s disease (2016 edition). Chin J Neurol. 2016;49(04):268\u201371.","journal-title":"Chin J Neurol"},{"issue":"13","key":"3995_CR12","first-page":"2720","volume":"32","author":"P Zhong","year":"2012","unstructured":"Zhong P, Xu F, Hou YR, Fu WB. Efficacy of moxibustion combined with drugs in the treatment of Parkinson\u2019s disease with liver and kidney insufficiency. Chin J Gerontol. 2012;32(13):2720\u20131.","journal-title":"Chin J Gerontol"},{"issue":"2","key":"3995_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0037-1602423","volume":"37","author":"ME Freitas","year":"2017","unstructured":"Freitas ME, Hess CW, Fox SH. Motor complications of dopaminergic medications in Parkinson\u2019s disease. Semin Neurol. 2017;37(2):147\u201357.","journal-title":"Semin Neurol"},{"key":"3995_CR14","doi-asserted-by":"crossref","unstructured":"Zahoor I, Shafi A, Haq E. Pharmacological Treatment of Parkinson\u2019s Disease. In: Stoker TB, Greenland JC, editors. Parkinson's disease: pathogenesis and clinical aspects. Brisbane (AU). 2018.","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch7"},{"issue":"8","key":"3995_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrneurol.2012.126","volume":"8","author":"M Coelho","year":"2012","unstructured":"Coelho M, Ferreira JJ. Late-stage Parkinson disease. Nat Rev Neurol. 2012;8(8):435\u201342.","journal-title":"Nat Rev Neurol"},{"key":"3995_CR16","doi-asserted-by":"publisher","first-page":"362494","DOI":"10.1093\/ecam\/neq047","volume":"2011","author":"EY Shen","year":"2011","unstructured":"Shen EY, Chen FJ, Chen YY, Lin MF. Locating the acupoint Baihui (GV20) beneath the cerebral cortex with MRI reconstructed 3D neuroimages. Evid Based Complement Alternat Med. 2011;2011:362494.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3995_CR17","doi-asserted-by":"crossref","unstructured":"Kwon S, Seo BK, Kim S. Acupuncture points for treating Parkinson\u2019s disease based on animal studies. Chin J Integr Med. 2016;22(10):723\u20137.","DOI":"10.1007\/s11655-016-2525-y"},{"key":"3995_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pbiomolbio.2020.04.001","volume":"155","author":"H Mao","year":"2020","unstructured":"Mao H, Zhao Y, Li H, Lei L. Ferroptosis as an emerging target in inflammatory diseases. Prog Biophys Mol Biol. 2020;155:20\u20138.","journal-title":"Prog Biophys Mol Biol"},{"issue":"1\u20132","key":"3995_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neulet.2005.04.068","volume":"384","author":"YK Kim","year":"2005","unstructured":"Kim YK, Lim HH, Song YK, Lee HH, Lim S, Han SM, et al. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. Neurosci Lett. 2005;384(1\u20132):133\u20138.","journal-title":"Neurosci Lett"},{"key":"3995_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fnagi.2018.00206","volume":"10","author":"Z Li","year":"2018","unstructured":"Li Z, Chen J, Cheng J, Huang S, Hu Y, Wu Y, et al. Acupuncture modulates the cerebello-thalamo-cortical circuit and cognitive brain Regions in patients of Parkinson\u2019s disease with tremor. Front Aging Neurosci. 2018;10:206.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"3995_CR21","first-page":"857","volume":"40","author":"XL Liu","year":"2020","unstructured":"Liu XL, Lu J, Tian Y, Zhang GY, Zhao CP, Wang TT, et al. Effect and mechanism of moxibustion on oxidative stress injury in rats with Parkinson\u2019s disease by activating Nrf2\/ARE pathway. Zhongguo Zhen Jiu. 2020;40(8):857\u201362.","journal-title":"Zhongguo Zhen Jiu"},{"issue":"1","key":"3995_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ctim.2005.06.003","volume":"14","author":"B Zhao","year":"2006","unstructured":"Zhao B, Wang X, Lin Z, Liu R, Lao L. A novel sham moxibustion device: a randomized, placebo-controlled trial. Complement Ther Med. 2006;14(1):53\u201360.\u00a0discussion 1.","journal-title":"Complement Ther Med"},{"issue":"1","key":"3995_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12906-016-1386-4","volume":"16","author":"C Bao","year":"2016","unstructured":"Bao C, Zhang J, Liu J, Liu H, Wu L, Shi Y, et al. Moxibustion treatment for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial. BMC Complement Altern Med. 2016;16(1):408.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"3995_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s13063-018-2794-1","volume":"19","author":"H Xu","year":"2018","unstructured":"Xu H, Zhao H, Kang L, Huang S, Shi Y, Su W, et al. Moxibustion using different habitat moxa floss for moderate to severe primary knee osteoarthritis: study protocol for a three-armed randomized, double-blinded, sham-controlled trial. Trials. 2018;19(1):403.","journal-title":"Trials"},{"issue":"4","key":"3995_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ctim.2009.01.002","volume":"17","author":"D Pach","year":"2009","unstructured":"Pach D, Brinkhaus B, Willich SN. Moxa sticks: thermal properties and possible implications for clinical trials. Complement Ther Med. 2009;17(4):243\u20136.","journal-title":"Complement Ther Med"},{"issue":"6","key":"3995_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/acm.2010.0072","volume":"17","author":"SY Kim","year":"2011","unstructured":"Kim SY, Yi SH, Cho JH, Yin CS, Lee H, Park HJ. Heat stimulation on the skin for medical treatment: can it be controlled? J Altern Complement Med. 2011;17(6):497\u2013504.","journal-title":"J Altern Complement Med"},{"key":"3995_CR27","doi-asserted-by":"publisher","first-page":"659584","DOI":"10.3389\/fphar.2021.659584","volume":"12","author":"L Wu","year":"2021","unstructured":"Wu L, Liu M, Liang J, Li N, Yang D, Cai J, et al. Ferroptosis as a new mechanism in Parkinson\u2019s disease therapy using traditional Chinese medicine. Front Pharmacol. 2021;12:659584.","journal-title":"Front Pharmacol"},{"key":"3995_CR28","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.pneurobio.2020.101890","volume":"196","author":"L Mahoney-Sanchez","year":"2021","unstructured":"Mahoney-Sanchez L, Bouchaoui H, Ayton S, Devos D, Duce JA, Devedjian JC. Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s disease. Prog Neurobiol. 2021;196:101890.","journal-title":"Prog Neurobiol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03995-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-03995-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03995-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T03:11:26Z","timestamp":1686539486000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-03995-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3995"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-03995-w","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"23 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This protocol was approved by the ethics committee of the Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine and registered in China Clinical Trial Registry (No. ChiCTR2000029745). All participants will sign written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no competing interests regarding the publication of this protocol.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}